Susquehanna International Group’s Theriva Biologics TOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-428
Closed -$4.61K 6578
2023
Q4
$4.61K Buy
+428
New +$4.61K ﹤0.01% 5778
2023
Q2
Sell
-427
Closed -$7.46K 6455
2023
Q1
$7.46K Buy
+427
New +$7.46K ﹤0.01% 5757
2022
Q4
Sell
-656
Closed -$16K 6743
2022
Q3
$16K Buy
656
+499
+318% +$12.2K ﹤0.01% 5764
2022
Q2
$8K Buy
157
+82
+109% +$4.18K ﹤0.01% 5533
2022
Q1
$5K Buy
+75
New +$5K ﹤0.01% 5613
2021
Q4
Sell
-88
Closed -$10K 6452
2021
Q3
$10K Buy
+88
New +$10K ﹤0.01% 5236
2021
Q1
Sell
-63
Closed -$6K 5767
2020
Q4
$6K Buy
+63
New +$6K ﹤0.01% 4718
2020
Q2
Sell
-984
Closed -$79K 4932
2020
Q1
$79K Buy
+984
New +$79K ﹤0.01% 4103
2019
Q4
Sell
-100
Closed -$11K 4810
2019
Q3
$11K Buy
100
+60
+150% +$6.6K ﹤0.01% 4337
2019
Q2
$6K Sell
40
-9
-18% -$1.35K ﹤0.01% 4430
2019
Q1
$8K Buy
+49
New +$8K ﹤0.01% 2889
2018
Q2
Sell
-4
Closed -$11K 4687
2018
Q1
$11K Buy
+4
New +$11K ﹤0.01% 3264
2017
Q3
Sell
-22
Closed -$107K 4200
2017
Q2
$107K Buy
22
+10
+83% +$48.6K ﹤0.01% 3235
2017
Q1
$68K Sell
12
-7
-37% -$39.7K ﹤0.01% 3021
2016
Q4
$128K Buy
+19
New +$128K ﹤0.01% 3849
2016
Q2
Sell
-48
Closed -$987K 4044
2016
Q1
$987K Buy
48
+21
+78% +$432K ﹤0.01% 2030
2015
Q4
$536K Buy
+27
New +$536K ﹤0.01% 2922
2015
Q2
Sell
-12
Closed -$238K 4739
2015
Q1
$238K Buy
+12
New +$238K ﹤0.01% 3643
2014
Q2
Sell
-16
Closed -$360K 4469
2014
Q1
$360K Buy
+16
New +$360K ﹤0.01% 2859